Joseph H. Capper - 18 Jun 2026 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Reporting relationship: Director
Issuer ticker: ANIK
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jun 2026, 16:30:09 UTC
Prior SEC filing: 11 Jun 2026
Next SEC filing: 17 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph H. Capper

Key filing fact

Joseph H. Capper filed Form 4 for Anika Therapeutics, Inc. (ANIK) on 23 Jun 2026.

Key facts

This page summarizes Joseph H. Capper's Form 4 filing for Anika Therapeutics, Inc. (ANIK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Jun 2026, 16:30.

Change

Previous filing in this sequence was filed on 11 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001456817 Primary reporting owner

Capper Joseph H

Relationship: Director
Address: C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD
Signature: /s/ Joseph H. Capper
Signature date: 23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIK transaction

Common Stock

Award

Transaction value
Shares: +10,402
Change %: +51%
Price: $0.000000^*
Shares after: 30,805
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.